Video Experimental Relacionado
Updated: May 11, 2026
08:59
Defining Substrate Specificities for Lipase and Phospholipase Candidates
Published on: November 23, 2016
El uso de inhibidores específicos de la isoforma para dirigirse a las kinasas lipídicas
1Clinical Research and Human Biology Divisions, Fred Hutchinson Cancer Research Center, D2-100, 1100 Fairview Avenue North, Seattle, WA 98109, USA. jsimon@fhcrc.org
Cell
|May 23, 2006
Resumen
Los inhibidores de moléculas pequeñas revelan que p110alpha, una isoforma de fosfoinositida 3-cinasa (PI3-K), es crucial para la señalización de la insulina. El bloqueo de la actividad de la p110alfa y la cinasa mTOR limita el crecimiento del glioma.
Área de la Ciencia:
- La bioquímica es la bioquímica.
- Biología Molecular Biología Molecular
- Farmacología Farmacología.
Sus antecedentes:
- Las vías de señalización de la fosfoinositida 3-cinasa (PI3-K) regulan procesos celulares cruciales.
- La desregulación de la señalización de PI3-K está implicada en varias enfermedades, incluido el cáncer y los trastornos metabólicos.
- Las isoformas específicas de PI3-K, como p110alpha, desempeñan funciones distintas en las funciones celulares.
Objetivo del estudio:
- Para llevar a cabo un análisis farmacológico detallado de la familia PI3-K utilizando inhibidores de moléculas pequeñas.
- Para aclarar el papel específico de las isoformas PI3-K en la señalización de la insulina.
- Investigar el potencial terapéutico de la inhibición de PI3-K y mTOR en el crecimiento del glioma.
Principales métodos:
- Se utilizaron inhibidores de moléculas pequeñas para el análisis farmacológico de la familia PI3-K.
- Investigó los efectos de los inhibidores en las vías de señalización de la insulina.
- Se evaluó el impacto de la inhibición combinada de p110alfa y mTOR en la proliferación de células de glioma.
Principales resultados:
- Identificó p110alpha como una isoforma crítica de PI3-K en la mediación de la señalización de la insulina.
- Se demostró que p110alfa juega un papel clave en la vía PI3-K.
- Se demostró que la inhibición de la actividad de la quinasa p110alfa y mTOR limita significativamente el crecimiento del glioma.
Conclusiones:
- p110alpha es un mediador crítico de la señalización de la insulina.
- Dirigirse a p110alpha y mTOR con inhibidores de moléculas pequeñas presenta una estrategia terapéutica potencial para los gliomas.
- La disección farmacológica de las isoformas PI3-K ofrece información sobre sus funciones biológicas específicas.
Videos de Conceptos Relacionados
01:42Phosphoinositides and PIPs
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
01:26Targets for Drug Action: Overview
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...